Oireachtas Joint and Select Committees
Wednesday, 8 November 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Mr. John Hennessy:
Regarding price negotiations and confidentiality, our preference would be that it would not be done in that manner and that it would be more transparent and open as a public body. Obviously, companies feel that they have to operate in a price-confidential manner in the process and, as Mr. Flanagan said, those negotiations do become protracted on some occasions.
No comments